Skip to content

Clinical trials

Observational Disease Progression trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Observational Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20111
20141
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen1
Eli Lilly and Company1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University1
Ontario Clinical Oncology Group (OCOG)1
University Health Network, Toronto1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression7
Multiple Sclerosis2
Amyotrophic Lateral Sclerosis1
Brain Neoplasms1
Connective Tissue Diseases1
Diabetes Mellitus1
Diabetes Mellitus, Type 21
Glioma1
Hypoglycemia1
Insulin Resistance1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.